MEDIA

2016.09.20 MEDIAAlvetex wins CV Technology Innovator Awards 2016

ReproCELL is proud to announce its groundbreaking 3D cell culture technology Alvetex has been awarded the Corporate Vision Technology Innovator Award 2016. Read the full interview with Prof. Dr. Stefan Przyborski, ReproCELL Europe’s Chief Scientific Officer and inventor of Alvetex, here: http://reinnervate.com/reprocell-europe-wins-cv-tech-innovator-awards-2016-alvetex/

2013.05.16 MEDIAWebinar: iPSC derived Cells & hiPSC/ES media June 4th 2013– 10 AM CEST

Webinar: iPSC derived Cells & hiPSC/ES media June 4th 2013– 10 AM CEST Please register from here; https://attendee.gotowebinar.com/register/7334590631056470272

2013.03.22 MEDIAReproCELL’s iPS cell technology featured in NHK World news

ReproCELL’s iPS cell technology featured in NHK World news http://www3.nhk.or.jp/nhkworld/english/movie/feature201303211118.html

2012.10.26 MEDIAArticle on human ES/iPSC-derived Cardiomyocytes published

An article written jointly by Kyoto University and ReproCELL was published in Cell Rep. 2012 Nov 29;2(5):1448-60.. “Small Molecule that Promotes Cardiac Differentiation of Human Pluripotent Stem Cells under Defined, Cytokine- and Xeno-free Conditions”

2012.10.11 MEDIAReproCELL’s iPS cell business introduced in Japanese TV news programs

ReproCELL’s iPS cell business was widely introduced in Japanese TV news on Prof. Shinya Yamanaka’s €Nobel Prize.

2012.01.18 MEDIAGEN article introduced ReproCELL’s technology

ReproCELL’s iPS cell-derived cardiomyocytes, neurons and hepatocytes were introduced in Genetic Engineering & Biotechnology News (GEN). Jan 15, 2012 (Vol. 32, No. 2) Stem Cell Applications Hasten into the Clinic

2010.07.01 MEDIAReproCELL featured in Genetic Engineering & Biotechnology News

An article in Genetic Engineering & Biotechnology News, “Pharma’s R&D Focus Shifting to Stem Cells -Investors’ Interest in These Cells Increases as Scientists Continue to Unleash Their Potential” introduces ReproCELL’s new cardiotoxicity assay using iPSCs, QTempo, as well as its neural stem cell research. Read the article

  • «
  • 1
  • »